According to new market research report "Melanoma Therapeutics Market by Cancer stage (Stage 0, Stage 1,Stage 2,Stage 4), by Cancer Type(Nodular Melanoma, Acral lentiginous Melanoma, Superficial Spreading Melanoma, Lentigno Maligna Melanoma, Amelanotic Melanoma, Others), by Diagnosis (Ultrasound, Blood tests, Dermatoscopy, Sentinel Lymph Node Biopsy, X-Rays, CT Scan), by Treatment (Early Melanoma, Advanced Melanoma-Biological Therapy, Targeted Therapy, Surgery, Chemotherapy, Radiotherapy, Immunotherapy) and by Region-Global Industry Analysis, Size, Share, Growth, Trends and Forecasts (2016-2021), published by MarketDataForecast™, the market is expected to reach USD 4.63 Billion by 2021 from USD 2.22 Billion in 2016, at a CAGR of 15.8%.